Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Financings Of The Fortnight Applies Its Own Lens To Early-Stage Investments

Jan 27 2012

• By Alex Lash and Amanda Micklus

Related Content

Austerity Holds Back VC Investing in European Biotech Companies in 2011

Jan 23 2012

Verastem Joins The Public Markets With A Strong IPO

Jan 27 2012

With $20.7 Million Series A Cash, RaNA Seeks To Be A Groundbreaker In Long Non-Coding RNA Therapeutics

Jan 18 2012

Related Companies

Verastem, Inc.

Neurocrine Biosciences, Inc.

Abbott

GSK plc

Boehringer Ingelheim GmbH

Prosensa Holding N.V

Ultragenyx Pharmaceutical Inc.

Orphazyme A/S

Translate Bio

Monsanto Company

Pfizer Inc.

Trius Therapeutics, Inc.

Bayer AG

Additional Topics

Business Strategies BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window